Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Preadipocyte proliferation is affected by norepinephrine

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:5508115
Beta-adrenergic stimulators are known to alter body composition profiles in experimental animals. The most prominent in vivo adaptations to beta-agonists are a decreased adipose tissue and concurrent increased muscle mass. Our lab has previously reported that norepinephrine - a beta/sub 1/-agonist - compromised preadipocyte growth in a primary cell culture system. Accordingly, this study continued to examine the effect of norepinephrine (NE) on in vitro preadipocyte proliferation. Stromalvascular cells, obtained from the inguinal pad of 4-5 week old Sprague-Dawley rats, were grown in culture for two weeks. Cells were treated with NE (1 ..mu..M) during the proliferative growth phase and labelled with /sup 3/H-thymidine on day 2 of culture. Following exponential growth, all cells were placed on a differentiation promoting media. Adipocytes (including differentiated preadipocytes) and stromal cells were separated using a density gradient, and /sup 3/H-thymidine was determined for both cell types. NE exposure for 2 or 4 days significantly reduced preadipocyte /sup 3/H-thymidine uptake, indicating an inhibition of mitotic growth. Future experiments will examine possible mechanism(s) involved in the catecholamine induced suppression of preadipocyte proliferation.
Research Organization:
Univ. of Georgia, Athens
OSTI ID:
5508115
Report Number(s):
CONF-8604222-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:3
Country of Publication:
United States
Language:
English